Mark A Wan's Net Worth
$13.7 Million
Who is Mark A Wan?
Mark A Wan has an estimated net worth of $13.7 Million. This is based on reported shares across multiple companies, which include LIPOSCIENCE INC, SOLTA MEDICAL INC, NORTH AMERICAN SCIENTIFIC INC, ODYSSEY HEALTHCARE INC, Athlon Acquisition Corp., NEVRO CORP, CONCERT PHARMACEUTICALS, INC., THRESHOLD PHARMACEUTICALS INC, ACELRX PHARMACEUTICALS INC, and EPOCRATES INC.
SEC CIK
Mark A Wan's CIK is 0001190472
Past Insider Trading and Trends
2011 was Mark A Wan's most active year for acquiring shares with 47 total transactions. Mark A Wan's most active month to acquire stocks was the month of January. 2011 was Mark A Wan's most active year for disposing of shares, totalling 52 transactions. Mark A Wan's most active month to dispose stocks was the month of January. 2012 saw Mark A Wan paying a total of $10,000,002.00 for 3,510,560 shares, this is the most they've acquired in one year. In 2006 Mark A Wan cashed out on 1,000,000 shares for a total of $14,500,000.00, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
ODYSSEY HEALTHCARE INC No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +77.80% | 2.42K |
$35.38 | $97,754.94 |
0
|
Sep 25 - Nov 24
| |||
Form 4
| -63.70% | -5.46K |
$34.64 | -$138,560.00 | 3.11K |
Sep 8
| |||
Form 4
| -29.06% | -3.51K |
$30.47 | -$106,858.29 | 8.56K |
Aug 27
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Athlon Acquisition Corp. No price found
Executive Chairman
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
NEVRO CORP (NVRO) Snapshot price: $17.03
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +52,962.15% | 2.21M |
—
|
—
| 2.21M |
Nov 12
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
CONCERT PHARMACEUTICALS, INC. No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -30.51% | -250.00K |
$12.29 | -$3,072,500.00 | 569.43K |
Nov 18
| |||
Form 4
| -30.51% | -250.00K |
$12.29 | -$3,072,500.00 | 569.43K |
Nov 18
| |||
Form 4
| +107.04% | 793.76K |
$14.00 | $1,449,000.00 | 1.54M |
Feb 19
| |||
Form 4
| +107.04% | 793.76K |
$14.00 | $1,449,000.00 | 1.54M |
Feb 19
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
THRESHOLD PHARMACEUTICALS INC (MTEM) Snapshot price: $3.7
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -29.07% | -1.00M |
$14.50 | -$14,500,000.00 | 2.44M |
Mar 3
| |||
Form 4
| +7.30% | 234K |
$7.00 | $1,637,986.00 | 3.44M |
Feb 9
| |||
Form 4
| +234.68% | 3.21M |
—
|
—
| 4.57M |
Feb 3
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||